The referred-to effect was further translated into a marked nucleolin-dependent therapeutic efficacy, supported by a significant tumor growth inhibition of orthotopic mesothelioma tumors, along with a decrease in the nucleolin-positive vasculature density and downregulation of typically overexpressed genes in patients [19]. The gene discussed is NUCLEOLIN; the disease is neoplasm.